Nuhey News

We talk about the MARKET

Atopic Dermatitis Drugs Market to make a new high by reaching USD 7514.8 Mn by 2028

Atopic dermatitis (AD) is a pruritic disease of unknown origin that usually starts in early infancy (an adult-onset variant is recognized).

Due to the COVID-19 pandemic, the global Atopic Dermatitis Drugs market size is estimated to be worth US$ 5406.8 million in 2021 and is forecast to a readjusted size of US$ 7514.8 million by 2028 with a CAGR of 4.7% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Atopic Dermatitis Drugs market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Atopic Dermatitis Drugs landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

One of the major factors responsible for the growing risk of severe atopic dermatitis in infancy is related to food sensitization, which is commonly associated with food allergy. It has been observed that these allergies mainly result from the cow’s milk, chicken eggs, peanuts, wheat, soy, nuts, and fish.

This report focuses on Atopic Dermatitis Drugs volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Atopic Dermatitis Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Request for a free sample or purchase this report at:

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Injectable
  • Oral
  • Tropical

Segment by Application

  • Hospital
  • Clinic

By Company

  • LEO Pharma
  • Mylan
  • Valeant
  • Bayer HealthCare
  • Encore Dermatology

Production by Region

  • North America
  • Europe
  • China

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)


Contact Details:

Mr. Shirish Gupta

Sales Manager

The Market Reports | Industry and Market Reports at its Best

Call: +1-631-407-1315 / +91-750-729-1479